Almost half of patients with RA who discontinue TNF inhibitor treatment after achieving remission will relapse, a meta-analysis by Australian authors shows. A systematic review of 16 randomised controlled trials of elective discontinuation of TNFis in RA patients in remission found an overall relapse rate of 47%. The duration of follow-up after withdrawal was over ...
Half of RA patients relapse after TNF inhibitor discontinuation
By Michael Woodhead
27 Mar 2019